Clinical Trial Update: Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) [Phase 3]

View source ↗

Summary

Phase 3 ACCORD Eye Study completed; results posted in 2013 evaluating how ACCORD diabetes treatments affect diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Diabetic Retinopathy | Phase 3 | Status: COMPLETED | Results posted: 2013-11-26